3-carboxy-4-methyl-5-propyl-2-furanpropionic acid has been researched along with indoleacetic acid in 12 studies
| Studies (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid) | Trials (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid) | Recent Studies (post-2010) (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid) | Studies (indoleacetic acid) | Trials (indoleacetic acid) | Recent Studies (post-2010) (indoleacetic acid) |
|---|---|---|---|---|---|
| 100 | 6 | 38 | 3,136 | 12 | 1,300 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mabuchi, H; Nakahashi, H | 3 |
| Otagiri, M; Sakai, T; Takadate, A | 1 |
| Deguchi, T; Kouno, Y; Otagiri, M; Takadate, A; Terasaki, T | 1 |
| Deguchi, T; Isozaki, K; Otagiri, M; Terasaki, T; Yousuke, K | 1 |
| Boelaert, J; Eloot, S; Glorieux, G; Lynen, F; Sandra, P; Van Landschoot, M; Vanholder, R; Waterloos, MA | 1 |
| Furukubo, T; Hiraoka, S; Hosoda, S; Izumi, S; Minegaki, T; Miyoshi, A; Nagano, Y; Nishiguchi, K; Shiraishi, A; Tsujimoto, M; Yamakawa, T | 1 |
| Dhondt, A; Eloot, S; Glorieux, G; Neirynck, N; Van Biesen, W; Vanholder, R | 1 |
| Furukubo, T; Izumi, S; Minegaki, T; Nishiguchi, K; Oda, T; Ogino, H; Shinmoto, T; Tachiki, H; Tsujimoto, M; Uchiyama, H; Yamakawa, T; Yoshida, T | 1 |
| Ichimura, Y; Ideuchi, H; Oda, M; Saitoh, H; Takamatsu, H; Takeda, K | 2 |
12 other study(ies) available for 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and indoleacetic acid
| Article | Year |
|---|---|
Inhibition of hepatic glutathione S-transferases by a major endogenous ligand substance present in uremic serum.
Topics: Animals; Cattle; Dinitrochlorobenzene; Furans; Glutathione Transferase; Humans; Indican; Indoleacetic Acids; Liver; Propionates; Protein Binding; Rats; Serum Albumin; Uremia | 1988 |
Displacement by anionic drugs of endogenous ligands bound to albumin in uremic serum.
Topics: Binding Sites; Furans; Hippurates; Humans; Indican; Indoleacetic Acids; Propionates; Protein Binding; Salicylates; Salicylic Acid; Serum Albumin; Uremia; Warfarin | 1988 |
Determination of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, a major endogenous ligand substance in uremic serum, by high-performance liquid chromatography with ultraviolet detection.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Female; Furans; Humans; Indoleacetic Acids; Male; Middle Aged; Propionates; Renal Dialysis; Serum Albumin; Spectrophotometry, Ultraviolet; Uremia | 1987 |
Characterization of binding site of uremic toxins on human serum albumin.
Topics: Binding Sites; Dansyl Compounds; Furans; Hippurates; Humans; Indoleacetic Acids; Indoles; Propionates; Sarcosine; Serum Albumin; Uremia; Warfarin | 1995 |
Differential contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in vivo renal uptake of uremic toxins in rats.
Topics: Animals; Biological Transport; Carbon Radioisotopes; Estrone; Furans; Hippurates; Indican; Indoleacetic Acids; Kidney; Male; Metabolic Clearance Rate; Organic Anion Transport Protein 1; Organic Cation Transport Proteins; p-Aminohippuric Acid; Penicillin G; Propionates; Rats; Rats, Wistar; Serum; Tritium | 2005 |
Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier.
Topics: Animals; Biological Transport; Blood-Brain Barrier; Brain; Female; Furans; Hippurates; Indoleacetic Acids; Kinetics; Male; Oocytes; Organic Anion Transporters; Propionates; Rats; Rats, Wistar; Uremia; Xenopus laevis | 2006 |
A novel UPLC-MS-MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients.
Topics: Cardiovascular Diseases; Case-Control Studies; Chromatography, High Pressure Liquid; Cresols; Female; Furans; Glucuronides; Hippurates; Humans; Indican; Indoleacetic Acids; Male; Propionates; Renal Insufficiency, Chronic; Severity of Illness Index; Sulfuric Acid Esters; Tandem Mass Spectrometry; Uremia; Uric Acid | 2013 |
Effects of decreased vitamin D and accumulated uremic toxin on human CYP3A4 activity in patients with end-stage renal disease.
Topics: Cell Line, Tumor; Cytochrome P-450 CYP3A; Erythromycin; Furans; Hippurates; Humans; Indican; Indoleacetic Acids; Kidney Failure, Chronic; Liver; Microsomes, Liver; Pregnane X Receptor; Propionates; Receptors, Calcitriol; Receptors, Steroid; RNA, Messenger; Steroid Hydroxylases; Toxins, Biological; Vitamin D; Vitamin D3 24-Hydroxylase | 2013 |
Does the adequacy parameter Kt/V(urea) reflect uremic toxin concentrations in hemodialysis patients?
Topics: Aged; Aged, 80 and over; beta 2-Microglobulin; Biomarkers; Creatinine; Cresols; Diabetes Mellitus; Female; Furans; Glucuronides; Hippurates; Humans; Indican; Indoleacetic Acids; Male; Middle Aged; Multivariate Analysis; Propionates; Renal Dialysis; Sulfuric Acid Esters; Treatment Outcome; Urea; Uremia; Uric Acid | 2013 |
Uremic toxins enhance statin-induced cytotoxicity in differentiated human rhabdomyosarcoma cells.
Topics: Apoptosis; Cell Differentiation; Cell Line, Tumor; Cell Survival; Drug Synergism; Furans; Hippurates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indican; Indoleacetic Acids; Pravastatin; Propionates; Rhabdomyosarcoma; Simvastatin; Toxins, Biological; Uremia | 2014 |
[Plasma concentrations of anionic uremic toxins in hemodialysis patients and their effects on protein binding of pravastatin].
Topics: Aged; Aged, 80 and over; Female; Furans; Humans; Indican; Indoleacetic Acids; Male; Middle Aged; Pravastatin; Propionates; Protein Binding; Renal Dialysis; Serum Albumin | 2015 |
Correlations between Plasma Levels of Anionic Uremic Toxins and Clinical Parameters in Hemodialysis Patients.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Urea Nitrogen; Creatinine; Female; Furans; Glomerular Filtration Rate; Humans; Indican; Indoleacetic Acids; Male; Middle Aged; Predictive Value of Tests; Propionates; Renal Dialysis; Renal Insufficiency, Chronic | 2016 |